Genic Co

Genic Co Equity

The The Equity of Genic Co (123330.KQ) as of Sep 20, 2026 is 41.05 B KRW. In the previous year, The Equity was 22.15 B KRW — a change of 85.28% (higher).

Equity

41.05 BKRW

YoY

85.28%

Last updated:

In 2026, Genic Co's equity was 41.05 B KRW, a 85.28% increase from the 22.15 B KRW equity in the previous year.

The Genic Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
38.94 B KRW
Jan 1, 2019
27.14 B KRW
Jan 1, 2020
22.33 B KRW
Jan 1, 2021
19.30 B KRW
Jan 1, 2022
15.94 B KRW
Jan 1, 2023
11.53 B KRW
Jan 1, 2024
22.15 B KRW
Jan 1, 2025
41.05 B KRW
The Genic Co Equity history
YEAREquityYoY
41.05 BKRW+85.28%
22.15 BKRW+92.12%
11.53 BKRW-27.67%
15.94 BKRW-17.38%
19.30 BKRW-13.59%
22.33 BKRW-17.72%
27.14 BKRW-30.31%
38.94 BKRW-28.25%
54.27 BKRW-12.37%
61.93 BKRW+6.70%
58.04 BKRW+5.23%
55.16 BKRW—
Access this data via the Eulerpool API
Get Free API Key

Genic Co Stock analysis

What does Genic Co do? Genic Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Genic Co's Equity

Genic Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Genic Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Genic Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Genic Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Genic Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Genic Co stock

The Equity of Genic Co is 41.05 B KRW in 2026.

The Equity of Genic Co changed from 22.15 B KRW to 41.05 B KRW, representing a 85.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Genic Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Genic Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Genic Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Genic Co